Showing results (321-330 of 360) with videos related to

Sort By:
Pageof 36
European Journal of Medicinal Chemistry|March 25, 2014
Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicityYahaira Santiago-Vazquez, Swagatika Das, Umashankar Das, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 11, 2019
Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndromeD Balemans, J Aguilera-Lizarraga, M V Florens, et al.
Bioorganic Chemistry|October 3, 2025
Novel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triple-negative breast cancer cellsNursyuhada Azzman, Muhammad Shoaib Ali Gill, Nurshariza Abdullah, et al.
Scientific Reports|August 12, 2021
A novel bis(pyrazolyl)methane compound as a potential agent against Gram-positive bacteriaPedro Seguí, John J Aguilera-Correa, Elena Domínguez-Jurado, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Methacrylate Cationic Nanoparticles Activity against Different Gram-Positive BacteriaSyong H Nam-Cha, Ana V Ocaña, Ramón Pérez-Tanoira, et al.
Laryngoscope Investigative Otolaryngology|February 14, 2022
A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externaAna V Ocaña, John J Aguilera-Correa, Elena Domínguez-Jurado, et al.
Actas Dermo-Sifiliograficas|January 1, 2026
EVALUATION OF THE EFFICACY OF PHOTOPROTECTIVE FORMULATIONS APPLIED IN CONJUNCTION WITH TOPICAL ACTIVE INGREDIENTS IN PATIENTS WITH PHOTODERMATOSESR Castillo-Muñoz, J Aguilera, E Navarrete-De Gálvez, et al.
Elife|May 27, 2014
miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesisElik Chapnik, Natalia Rivkin, Alexander Mildner, et al.
BMC Medical Research Methodology|March 6, 2021
Design and implementation of a massive open online course on enhancing the recruitment of minorities in clinical trials - Faster TogetherSheila V Kusnoor, Victoria Villalta-Gil, Margo Michaels, et al.
Pageof 36